Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS Report 1)

Acta Ophthalmologica

Volumn 91, Issue 1, 2013, Pages

  Oréfice, Juliana L ^a   Costa, Rogério A ^a,b,c   Scott, Ingrid U ^d   Calucci, Daniela ^b   Oréfice, Fernando ^a  

^a Division of Macula Imaging and Treatment   (Brazil)

^b Hospital de Olhos de Araraquara   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

chorioretinitis eye infections; optical coherence; parasitic; tomography; uveitis

Indexed keywords

FOLINIC ACID; PREDNISONE; PYRIMETHAMINE; SULFADIAZINE;

ADOLESCENT; ADULT; ARTICLE; BRUCH MEMBRANE; CHILD; CHORIORETINITIS; CHOROID CAPILLARY LAYER; CLINICAL ARTICLE; EYE FUNDUS; EYE INFECTION; EYE REFRACTION; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA; RETINAL REFLECTIVE LAYER; SNELLEN CHART; SPECTRAL OPTICAL COHERENCE TOMOGRAPHY; TOXOPLASMOSIS; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; VISUAL SYSTEM PARAMETERS; VITREOUS BODY;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHORIORETINITIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; TOMOGRAPHY, OPTICAL COHERENCE; TOXOPLASMA; TOXOPLASMOSIS, OCULAR; VISUAL ACUITY; YOUNG ADULT;

EID: 84873057840     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2012.02531.x     Document Type: Article

References (29)

1. de Boer JF, Cense B, Park BH, Pierce MC, Tearney GJ, &, Bouma BE, (2003): Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett 28: 2067-2069.
2. Bosch-Driesssen EH, Berendschot TJM, Ongkosuwito JV, &, Rothova A, (2002): Ocular toxoplasmosis clinical features and prognosis of 154 patients. Ophthalmology 109: 869-878.
3. Charbel Issa P, Foerl M, Helb HM, Scholl HP, &, Holz FG, (2008): Multimodal fundus imaging in foveal hypoplasia: combined scanning laser ophthalmoscope imaging and spectral-domain optical coherence tomography. Arch Ophthalmol 126: 1463-1465.
4. Choma MA, Sarunic MV, Yang CH, &, Izatt JA, (2003): Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt Express 11: 2183-2189.
5. Diniz B, Regatieri C, Andrade R, &, Maia A, (2011): Evaluation of spectral domain and time domain optical coherence tomography findings in toxoplasmic retinochoroiditis. Clin Ophthalmol 5: 645-650.
6. Doft BH, &, Gass JDM, (1985): Punctate Outer retinal toxoplasmosis. Arch Ophthalmol 103: 1332-1336.
7. Dudgeon SM, Keating D, &, Parks S, (2007): Simultaneous structural and functional imaging of the macula using combined optical coherence tomography ophthalmoscope and multifocal electroretinogram. J Opt Soc Am A Opt Image Sci Vis 24: 1394-1401.
8. Fernandes LC, &, Oréfice F, (1996): Aspectos clinicos e epidemiolõgicos das uveítes em serviço de referência em Belo Horizonte 1970-1993. Rev Bras Oftlamol 55: 569-578.
9. Ferrara DC, Costa RA, Tsang S, Calucci D, Jorge R, &, Freund KB, (2010): Multimodal fundus imaging in Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol 248: 1377-1386.
10. Friedman CT, &, Knox DL, (1969): Variations in recurrent active toxoplasmis retinochoroiditis. Arch Ophthalmol 81: 481-493.
11. Guagnini AP, De Potter P, Levecq L, &, Kozyreff A, (2007): Atypical spherical deposition on vitreoretinal interface associated with toxoplasmic chorioretinitis. Graefes Arch Clin Exp Ophthalmol 245: 158-160.
12. Holland GN, (2003): Ocular toxoplasmosis: a global reassessment. Part 1: epidemiology and course of disease. Am J Ophthlmol 136: 973-988.
13. Holland GN, Buhles WC, Mastre B, &, Kaplan HJ, (1989): A controlled retrospective study of ganciclovir tretament for cytomegalovirus retinopathy. Use of standartized system for the assessment of disease outcome. Arch Ophthalmol 107: 1759-1766.
14. Hovakimyan A, &, Cunningham ET Jr, (2002): Ocular toxoplasmosis. Ophthalmol Clin North Am 15: 327-332.
15. Jabs DA, Nussemblatt RB, Rosenbum JT, et al., (2005): Standardization of uveitis nomeclature for reporting clinical data. Results of the first internacional workshop. Am J Ophthalmol 140: 509-516.
16. Jankû J, (1923): Pathogenesa a Pathologická Anatomie T. Zv. Vrozeneho Kolobomu Zlute Skurny Oku Normál ne Velikém. A Mikrophthalmikem s Nalezem Parasitu v Sitnici. Cas Lék Ces 62: 1021-1027.
17. Johnson MW, Greven CM, Jaffe GJ, Sudhalkar H, &, Vine AK, (1997): Atypical severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 104: 48-57.
18. Leitgeb R, Hitzenberger CK, &, Fercher AF, (2003): Performance of Fourier domain vs. time domain optical coherence tomography. Opt Express 11: 889-894.
19. Matthews JD, &, Weiter JJ, (1988): Outer Retina Toxoplasmosis. Ophthalmology 95: 941-946.
20. McCannel C, Holland GN, Helm CJ, et al., (1996): Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol 121: 35-46.
21. Moshfeghi DM, Lowder CY, Dodds EM, et al., (2004): Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 111: 716-725.
22. Oréfice JL, Costa RA, Campos W, Calucci D, Scott IU, &, Oréfice F, (2006): Third-generation optical coherence tomography findings in punctate retinal toxoplasmosis. Am J Ophthalmol 142: 503-505.
23. Oréfice JL, Costa RA, Oréfice F, Campos W, da Costa-Lima D Jr, &, Scott IU, (2007): Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography. Br J Ophthalmol 91: 773-780.
24. Pavesio CE, &, Lightman S, (1996): Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol 80: 1099-1107.
25. Reeves GM, Kumar N, Beare NA, &, Pearce IA, (2011): Use of Staurenghi lens angiography in the management of posterior uveitis. Acta Ophthalmol. [Epub ahead of print].
26. Roesel M, Heimes B, Heinz C, Henschel A, Spital G, &, Heiligenhaus A, (2011): Comparison of retinal thickness and fundus-related microperimetry with visual acuity in uveitic macular oedema. Acta Ophthalmol 89: 533-537.
27. Spaide RF, Noble K, Morgan A, &, Freund KB, (2006): Vitelliform macular dystrophy. Ophthalmology 113: 1392-1400.
28. Wojtkowski M, Leitgeb R, Kowalczyk A, Bajraszewski T, &, Fercher AF, (2002): In vivo human retinal imaging by Fourier domain optical coherence tomography. J Biomed Opt 7: 457-463.
29. Wojtkowski M, Bajraszewski T, Targowski P, &, Kowalczyk A, (2003): Real-time in vivo imaging by high-speed spectral optical coherence tomography. Opt Lett 28: 1745-1747.